Tell2Adapt: A Unified Framework for Source Free Unsupervised Domain Adaptation via Vision Foundation Model
Organizations: College of Medicine and Biological Information Engineering, Northeastern University · Engineering Research Center of Medical Imaging and Intelligent Analysis, Ministry of Education · Key Laboratory of Medical Image Computing, Ministry of Education, Northeastern University
Abstract
Source Free Unsupervised Domain Adaptation (SFUDA) is critical for deploying deep learning models across diverse clinical settings. However, existing methods are typically designed for low-gap, specific domain shifts and cannot generalize into a unified, multi-modalities, and multi-target framework, which presents a major barrier to real-world application. To overcome this issue, we introduce Tell2Adapt, a novel SFUDA framework that harnesses the vast, generalizable knowledge of the Vision Foundation Model (VFM). Our approach ensures high-fidelity VFM prompts through Context-Aware Prompts Regularization (CAPR), which robustly translates varied text prompts into canonical instructions. This enables the generation of high-quality pseudo-labels for efficiently adapting the lightweight student model to target domain. To guarantee clinical reliability, the framework incorporates Visual Plausibility Refinement (VPR), which leverages the VFM's anatomical knowledge to re-ground the adapted model's predictions in target image's low-level visual features, effectively removing noise and false positives. We conduct one of the most extensive SFUDA evaluations to date, validating our framework across 10 domain adaptation directions and 22 anatomical targets, including brain, cardiac, polyp, and abdominal targets. Our results demonstrate that Tell2Adapt consistently outperforms existing approaches, achieving SOTA for a unified SFUDA framework in medical image segmentation. Code are avaliable at https://github.com/derekshiii/Tell2Adapt.
Figures & tables
| Original Prompts | Regularized Prompts |
|---|---|
| Liverr [SEP] Spleen CT [SEP] Abdomen duodenum | Liver in abdomen CT [SEP] Spleen in abdomen CT [SEP] Duodenum in abdomen CT |
| Right ventricle [SEP] Myocardium MRI [SEP] Left ventricle | Right ventricle in cardiac MRI [SEP] Myocardium in cardiac MRI [SEP] Left ventricle in cardiac MRI |
| MR CT | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Methods | VFM | Spleen | R. K | L. K | Gallb | Esoph | Liver | Stom | Aortic | V-Cava | Pancr | R. Adre | L. Adre | Duod | Bladder | Pros/Uter | mDICE |
| Baseline | 65.1 30.4 | 71.2 26.9 | 63.2 29.6 | 27.2 27.7 | 42.2 22.1 | 82.2 9.9 | 46.9 28.6 | 72.0 20.3 | 61.7 23.7 | 55.7 23.3 | 39.7 22.8 | 44.7 24.2 | 38.5 22.4 | 0.0 0.0 | 0.0 0.0 | 47.4 24.7 | |
| Supervised | 97.2 1.7 | 96.4 1.7 | 94.7 11.7 | 86.0 13.6 | 84.1 10.0 | 97.6 1.0 | 93.1 5.1 | 95.3 2.8 | 90.2 5.7 | 83.7 12.9 | 77.8 11.0 | 78.9 11.7 | 81.6 10.9 | 83.3 19.3 | 85.5 7.0 | 88.4 7.5 | |
| UPL [ 21 ] | 23.9 2.0 | 7.7 0.2 | 30.2 26.9 | 0.0 0.0 | 12.5 12.7 | 23.6 30.9 | 10.7 12.2 | 9.3 10.0 | 0.7 1.4 | 8.6 8.3 | 0.0 0.0 | 0.0 0.0 | 2.0 7.2 | 0.0 0.0 | 0.0 0.0 | 8.6 9.4 | |
| ProtoContra [ 24 ] | 5.6 6.3 | 11.9 2.3 | 7.3 2.6 | 4.3 3.1 | 37.5 24.1 | 40.1 24.8 | 25.1 21.3 | 38.6 27.8 | 29.2 18.9 | 39.1 20.1 | 0.0 0.0 | 0.0 0.0 | 17.6 16.2 | 0.0 0.0 | 0.0 0.0 | 17.1 15.9 | |
| IAPC [ 3 ] | 8.7 4.5 | 4.5 2.3 | 1.9 1.4 | 1.3 1.5 | 4.5 11.3 | 15.2 2.1 | 14.3 5.6 | 9.7 5.0 | 4.6 1.1 | 2.0 0.6 | 0.0 0.0 | 0.0 0.0 | 2.2 7.4 | 19.8 16.8 | 7.2 6.8 | 6.4 6.1 | |
| Methods | VFM | T1n T2w | T2w T1n | ||||||||||||||
| DICE (%, mean std) | ASD (mm, mean std) | DICE (%, mean std) | ASD (mm, mean std) | ||||||||||||||
| TC | SNFH | ET | RC | TC | SNFH | ET | RC | TC | SNFH | ET | RC | TC | SNFH | ET | RC | ||
| Baseline | 19.7 29.1 | 7.5 7.4 | 4.7 5.6 | 30.0 24.9 | 40.6 17.8 | 21.2 8.6 | 40.2 18.8 | 58.9 25.7 | 4.6 4.8 | 13.9 10.5 | 3.2 4.9 | 25.9 38.1 | 48.4 22.9 | 19.4 7.6 | 38.1 15.9 | 57.1 20.6 | |
| Supervised | 61.9 20.8 | 84.3 7.3 | 68.0 14.8 | 86.6 10.9 | 2.9 5.1 | 1.3 0.5 | 1.8 1.9 | 1.0 3.0 | 62.8 20.7 | 83.6 6.7 | 71.6 14.9 | 83.9 14.3 | 2.3 2.5 | 1.4 0.6 | 1.8 2.4 | 1.2 2.9 | |
| UPL [ 21 ] | 47.2 23.4 | 36.9 22.5 | 61.7 48.6 | 46.7 23.5 | 33.6 22.8 | 33.5 20.8 | 6.8 6.1 | 29.5 23.1 | 46.5 34.1 | 10.7 12.1 | 60.3 48.9 | 38.7 24.6 | 16.5 12.8 | 56.9 22.1 | 23.2 14.3 | 22.9 17.0 | |
| ProtoContra [ 24 ] | 0.7 2.3 | 4.9 12.3 | 6.1 1.9 | 15.9 17.8 | 19.7 14.3 | 52.2 16.4 | 30.6 5.6 | 35.0 16.8 | 0.7 1.6 | 11.6 15.1 | 0.4 3.6 | 0.7 0.6 | 55.8 17.5 | 61.4 22.7 | 36.2 21.7 | 52.7 31.6 | |
| Methods | VFM | MR US | US MR | ||||||
| DICE (%, mean std) | ASD (mm, mean std) | DICE (%, mean std) | ASD (mm, mean std) | ||||||
| LV | MYO | LV | MYO | LV | MYO | LV | MYO | ||
| Baseline | 1.7 0.7 | 3.1 0.3 | 56.2 37.2 | 66.9 42.3 | 3.2 0.6 | 1.8 0.3 | 60.5 34.9 | 56.8 27.5 | |
| Supervised | 94.4 2.7 | 88.1 4.6 | 3.2 1.6 | 4.1 1.3 | 95.8 3.8 | 91.2 2.1 | 0.3 0.1 | 0.3 0.1 | |
| UPL [ 21 ] | 2.8 0.1 | 0.0 0.0 | 90.5 3.2 | 0.0 0.0 | 0.5 0.4 | 2.9 2.1 | 88.9 9.6 | 85.6 11.6 | |
| ProtoContra [ 24 ] | 1.2 1.2 | 17.0 7.2 | 54.9 14.2 | 56.4 13.9 | 5.2 5.8 | 4.9 3.2 | 72.9 12.4 | 74.8 10.5 | |
| Methods | VFM | Kvasir CVCDB | CVCDB Kvasir | ||
|---|---|---|---|---|---|
| DICE (%, mean std) | ASD (mm, mean std) | DICE (%, mean std) | ASD (mm, mean std) | ||
| Baseline | 65.1 21.5 | 5.8 11.1 | 60.2 27.0 | 23.7 20.4 | |
| Supervised | 99.8 0.1 | 0.36 0.1 | 97.4 1.3 | 0.9 1.1 | |
| UPL [ 21 ] | 67.1 14.6 | 2.2 0.9 | 60.2 31.3 | 11.4 17.2 | |
| ProtoContra [ 24 ] | 78.0 12.1 | 0.9 0.6 | 68.9 26.4 | 9.5 15.0 | |
| IAPC [ 3 ] | 73.3 29.6 | 4.4 7.9 | 61.2 26.3 | 13.7 13.2 | |
| MR CT | ||||||||||||||||
| Methods | Spleen | R. K | L. K | Gallb | Esoph | Liver | Stom | Aortic | V-Cava | Pancr | R. Adre | L. Adre | Duod | Bladder | Pros/Uter | mDICE |
| Baseline | 65.1 30.4 | 71.2 26.9 | 63.2 29.6 | 27.2 27.7 | 42.2 22.1 | 82.2 9.9 | 46.9 28.6 | 72.0 20.3 | 61.7 23.7 | 55.7 23.3 | 39.7 22.8 | 44.7 24.2 | 38.5 22.4 | 0.0 0.0 | 0.0 0.0 | 47.4 24.7 |
| Ours w/o CAPR (Chaotic Prompts) | 85.2 1.5 | 0.0 0.0 | 88.3 2.5 | 84.4 10.0 | 84.7 9.4 | 0.0 0.0 | 0.0 0.0 | 85.4 2.1 | 69.7 13.7 | 0.0 0.0 | 70.5 7.6 | 0.0 0.0 | 81.7 6.1 | 0.0 0.0 | 83.7 8.2 | 48.9 37.1 |
| Ours w/o CAPR (Normal Prompts) | 91.1 2.2 | 92.0 4.7 | 89.9 3.3 | 84.6 7.2 | 87.5 2.1 | 92.4 3.5 | 85.8 4.9 | 88.4 5.2 | 90.2 5.7 | 81.1 6.8 | 75.4 9.8 | 73.9 3.7 | 78.2 5.4 | 83.4 6.0 | 88.3 7.2 | 85.5 6.7 |
| Ours w/o VPR (Normal Prompts) | 90.1 2.3 | 91.8 3.7 | 92.5 4.4 | 80.2 12.1 | 83.2 6.1 | 94.9 3.3 | 90.0 7.6 | 91.8 4.1 | 90.1 5.8 | 80.6 11.6 | 72.7 8.0 | 74.6 9.7 | 75.4 16.8 | 82.3 14.4 | 84.9 7.0 | 85.0 7.4 |
| Ours (Chaotic Prompts) | 96.9 1.4 | 96.0 1.3 | 95.7 1.5 | 85.4 10.2 | 85.2 6.6 | 96.8 7.8 | 90.5 10.8 | 93.3 2.1 | 91.5 4.0 | 85.6 5.6 | 77.3 9.9 | 78.4 11.3 | 80.8 6.1 | 83.1 11.0 | 49.2 7.6 | 85.7 12.6 |
Appendix figures & tables6 assets
Supplementary material from the paper’s appendix.
Appendix
| MR CT | |||||||||||||||||
| Methods | VFM | Spleen | R. K | L. K | Gallb | Esoph | Liver | Stom | Aortic | V-Cava | Pancr | R. Adre | L. Adre | Duod | Bladder | Pros/Uter | mASD |
| Baseline | 17.5 19.2 | 17.2 18.5 | 15.5 17.8 | 23.1 30.7 | 7.8 9.6 | 11.4 7.2 | 15.3 14.6 | 8.9 9.9 | 6.9 11.2 | 9.1 10.7 | 4.7 3.4 | 4.8 4.2 | 10.3 9.7 | N/A | N/A | 13.0 4.8 | |
| Supervised | 1.1 0.3 | 1.1 0.8 | 1.2 1.4 | 1.2 2.4 | 0.8 0.7 | 2.3 0.5 | 1.9 1.6 | 1.1 1.3 | 1.0 0.4 | 1.4 1.0 | 0.7 0.7 | 0.7 0.7 | 1.6 1.1 | 1.9 1.9 | 2.7 7.7 | 1.4 0.6 | |
| UPL [ 21 ] | 79.0 19.9 | 87.2 15.2 | 72.4 17.6 | N/A | 14.8 17.6 | 37.0 20.6 | 31.6 21.5 | 23.7 12.8 | 50.2 15.4 | 29.3 16.7 | N/A | N/A | 54.4 23.4 | N/A | N/A | 48.0 23.6 | |
| ProtoContra [ 24 ] | 99.5 25.5 | 72.6 16.3 | 67.9 18.4 | 94.1 27.6 | 34.4 26.9 | 75.6 30.4 | 59.4 19.0 | 24.8 16.3 | 37.1 15.1 | 30.8 15.1 | N/A | N/A | 45.8 18.7 | N/A | N/A | 58.4 24.6 | |
| IAPC [ 3 ] | 92.3 80.2 | 65.2 19.9 | 69.8 21.2 | 82.0 37.9 | 25.8 14.7 | 54.4 31.0 | 77.6 47.8 | 29.9 20.0 | 27.7 15.5 | 54.2 32.7 | N/A | N/A | 45.3 25.0 | 31.1 18.2 | 31.2 19.7 | 54.9 22.2 | |
| MR CT | ||||||||||||||||
| Methods | Spleen | R. K | L. K | Gallb | Esoph | Liver | Stom | Aortic | V-Cava | Pancr | R. Adre | L. Adre | Duod | Bladder | Pros/Uter | mASD |
| Baseline | 17.5 19.2 | 17.2 18.5 | 15.5 17.8 | 23.1 30.7 | 7.8 9.6 | 11.4 7.2 | 15.3 14.6 | 8.9 9.9 | 6.9 11.2 | 9.1 10.7 | N/A | N/A | 10.3 9.7 | N/A | N/A | 13.0 4.8 |
| Ours w/o CAPR (Chaotic Prompts) | 1.7 1.1 | N/A | 2.5 0.5 | 2.6 1.4 | 2.6 0.8 | N/A | N/A | 2.4 0.7 | 5.4 9.3 | N/A | 1.7 0.4 | N/A | 3.9 2.4 | N/A | 2.6 2.5 | 2.8 1.1 |
| Ours w/o CAPR (Normal Prompts) | 1.5 0.9 | 2.2 0.4 | 2.1 1.5 | 2.6 0.8 | 1.7 0.9 | 3.3 1.5 | 2.7 0.4 | 2.0 1.9 | 4.7 2.6 | 1.9 1.1 | 1.5 0.4 | 2.1 1.4 | 2.2 1.9 | 2.9 1.1 | 2.4 0.7 | 2.4 8 |
| Ours w/o VPR (Normal Prompts) | 2.1 1.5 | 2.4 1.3 | 2.4 2.1 | 2.9 1.8 | 2.5 0.7 | 3.5 3.0 | 3.7 2.9 | 2.2 1.7 | 5.3 4.8 | 2.6 1.8 | 1.5 1.2 | 2.4 0.9 | 3.1 1.7 | 3.4 2.7 | 2.6 3.3 | 2.8 0.9 |
| Ours (Chaotic Prompts) | 1.2 0.4 | 2.3 0.1 | 1.3 0.4 | 2.8 2.4 | 1.5 0.5 | 2.3 0.2 | 2.1 5.5 | 1.4 0.9 | 1.5 0.2 | 0.9 0.4 | 0.9 4.2 | 1.0 4.4 | 3.8 0.9 | 1.7 2.0 | 1.8 1.5 | 1.8 0.8 |
| Target | Chaos Prompt in MR CT | Chaos Prompt in CT MR |
|---|---|---|
| Spleen | abdominal in CT Spleen. | pSleen MR in abdomianl. |
| Right Kidney | Right idney in abdominal CT. | MR kidey in Right abdominal. |
| Left Kidney | Left abdominl kdne in CT. | Lewt kdiney in abdominl MR. |
| Gallbladder | Gallbladedr in abdominal CT. | Gallbladder in abdomital MR. |
| Esophagus | in CT abdominal Esophagus. | abdominal in MR Esophagus. |
| Liver | Liiver in abdominal CT. | abdminal in MR Liver. |
| Target | Prompt in MR CT | Prompt in CT MR |
|---|---|---|
| Spleen | Spleen in abdominal CT. | Spleen in abdominal MR. |
| Right Kidney | Right kidney in abdominal CT. | Right kidney in abdominal MR. |
| Left Kidney | Left kidney in abdominal CT. | Left kidney in abdominal MR. |
| Gallbladder | Gallbladder in abdominal CT. | Gallbladder in abdominal MR. |
| Esophagus | Esophagus in abdominal CT. | Esophagus in abdominal MR. |
| Liver | Liver in abdominal CT. | Liver in abdominal MR. |
| Target | Prompt in T1n T2w | Prompt in T2w T1n | Prompt in T1c T2f | Prompt in T2f T1c |
|---|---|---|---|---|
| TC | Non-enhancing tumor core in head T2 weighted MR. | Non-enhancing tumor core in head MR naive T1. | Non-enhancing tumor core in head MR T2 FLAIR. | Non-enhancing tumor core in head post-contrast T1 MR. |
| SNFH | Surrounding non-enhancing FLAIR hyperintensity in head T2 weighted MR | Surrounding non-enhancing FLAIR hyperintensity in head MR naive T1. | Surrounding non-enhancing FLAIR hyperintensity in head MR T2 FLAIR. | Surrounding non-enhancing FLAIR hyperintensity in head post-contrast T1 MR. |
| ET | Enhancing tissue in head T2 weighted MR. | Enhancing tissue in head MR naive T1. | Enhancing tissue in head MR T2 FLAIR. | Enhancing tissue in head post-contrast T1 MR. |
| RC | Resection cavity in head T2 weighted MR. | Resection cavity in head MR naive T1. | Resection cavity in head MR T2 FLAIR. | Resection cavity in head post-contrast T1 MR. |
| Target | Prompt in MR US | Prompt in US MR |
|---|---|---|
| Left Ventricle | Left ventricle in heart ultrasound. | Left ventricle in cardiac MRI. |
| Myocardium | Myocardium in heart ultrasound. | Myocardium in cardiac MRI. |
| Target | Prompt in Kvasir CVCDB | Prompt in CVCDB Kvasir |
| Polyp | Polyp in colon endoscopes. | Polyp in colon endoscopes. |